Current status and influencing factors of knowledge, attitude and practice of drug clinical trials among ovarian cancer patients
10.3760/cma.j.cn115682-20191012-03662
- VernacularTitle:卵巢癌患者药物临床试验的知信行水平调查及影响因素分析
- Author:
Feifei ZHANG
1
;
Hemei WANG
;
Yao WANG
;
Shuying LIU
;
Rui ZHANG
;
Yan LOU
Author Information
1. 中国科学院大学附属肿瘤医院204西病区，杭州 310022
- Keywords:
Ovarian neoplasms;
Drug clinical trial;
Knowledge, attitude and practice level;
Influencing factors;
Health education
- From:
Chinese Journal of Modern Nursing
2020;26(25):3504-3507
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the current status and influencing factors of knowledge, attitude and practice of drug clinical trials among ovarian cancer patients.Methods:We selected 268 ovarian cancer patients from a ClassⅢ Grade A cancer hospital in Zhejiang Province from January to December 2018 by convenience sampling. The mature Knowledge, Attitude and Practice Questionnaire was used to investigate the current status of knowledge, attitude and practice in drug clinical trials. According to the survey results, patients were divided into the high cognition group and the low cognition group. Univariate and multivariate Logistic regression were used to analyze the influencing factors.Results:Among 268 patients, the scores of knowledge, attitude and practice were (31.67±3.59) , (16.35±2.71) and (10.56±1.43) respectively. Univariate analysis showed that there were statistical differences in knowledge, attitude and practice among patients with different education levels, residence places, medical insurance, occupation, fertility, medical attention, medical relatives and friends, and annual income ( P<0.05) . Multivariate analysis indicated that the influencing factors of knowledge, attitude and practice in drug clinical trials of ovarian patients included education levels, medical insurance, medication attention and annual income. Conclusions:Patients with ovarian cancer are not optimistic about the level of knowledge, attitude and practice in drug clinical trials, which clinical nurses should pay great attention to. We should carry out individualized health education for patients with different backgrounds and characteristics.
